BML-265
BML-265 is a potent and selective EGFR tyrosine kinase inhibitor that induces Golgi apparatus disruption and impairs secretory protein transport in human cells, while showing no such effect in rodent cells. This species-specific mechanism makes it a valuable research tool for studying EGFR signaling, Golgi biology, and protein trafficking in vitro.
Product Specifications
CAS Number
183321-62-2
Field of Research
Cardiovascular Research, Signal Transduction
Smiles
C#CC1=CC=CC (=C1) NC=2N=CN=C3C=C (OC) C (OC) =CC32
Molecular Formula
C18H15N3O2
Molecular Weight
305.331
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
LV734196 1.0 µg DNA
MRX75 Lentiviral Vector (Human) (CMV) (pLenti-GIII-CMV-C-term-HA)
Sign In for Pricing
View Details MBS2042949-01 0.1 mL
APC/CY7-Linked Polyclonal Antibody to Endothelin Converting Enzyme 1 (ECE1)
Sign In for Pricing
View Details MBS2042949-02 0.2 mL
APC/CY7-Linked Polyclonal Antibody to Endothelin Converting Enzyme 1 (ECE1)
Sign In for Pricing
View Details MBS2042949-03 0.5 mL
APC/CY7-Linked Polyclonal Antibody to Endothelin Converting Enzyme 1 (ECE1)
Sign In for Pricing
View Details MBS2042949-04 1 mL
APC/CY7-Linked Polyclonal Antibody to Endothelin Converting Enzyme 1 (ECE1)
Sign In for Pricing
View Details